Daiichi Sankyo Expands DS-1062 Study to Include Patients with Triple Negative Breast Cancer Read more
Aligos Therapeutics and KU Leuven Announce Collaboration for the Development of a Therapeutic Candidate Targeting Coronavirus Read more
FDA Grants ODD for Prestige BioPharma’s PBP1510 Anti-PAUF Monoclonal Antibody for the Treatment of Pancreatic Cancer Read more
FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma Read more
Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Read more
FDA Approves Merck’s KEYTRUDA for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer Read more
VITRAC Therapeutics Initiated Global Clinical Development of VIC-1911, licensed from Taiho Pharmaceutical Read more